Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868604
Status:
RECRUITING
Last Update Posted:
2024-03-27
First Post:
2021-04-15
Brief Title:
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer SECuRE
Sponsor:
Clarity Pharmaceuticals Ltd
Organization:
Clarity Pharmaceuticals Ltd
Organization Data
Organization:
Clarity Pharmaceuticals Ltd
Class:
INDUSTRY
Study ID:
CLP05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Clarity Pharmaceuticals Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None